These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25526208)

  • 1. Association between p53 codon 72 polymorphisms and clinical outcome of nasopharyngeal carcinoma.
    Li ML; Dong Y; Hao YZ; Xu N; Ning FL; Chen SS; Yu JM
    Genet Mol Res; 2014 Dec; 13(4):10883-90. PubMed ID: 25526208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between single nucleotide polymorphisms in the p53 pathway and response to radiotherapy in patients with nasopharyngeal carcinoma.
    Xie X; Jin H; Hu J; Zeng Y; Zhou J; Ouyang S; Yang W; Hu B; Wang H
    Oncol Rep; 2014 Jan; 31(1):223-31. PubMed ID: 24173110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinoma.
    Xie X; Wang H; Jin H; Ouyang S; Zhou J; Hu J; Xi X; Luo J; Zhang Y; Hu B
    Radiat Oncol; 2013 May; 8():117. PubMed ID: 23663243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free survival after curative radiotherapy for nasopharyngeal carcinoma.
    Jin H; Xie X; Wang H; Hu J; Liu F; Liu Z; Zhou J; Zhang Y; Xi X; Hu B; Liao Y; Tang J
    PLoS One; 2014; 9(7):e101256. PubMed ID: 25025378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 codon 72 polymorphism in Thai nasopharyngeal carcinoma.
    Tiwawech D; Srivatanakul P; Karaluk A; Ishida T
    Cancer Lett; 2003 Jul; 198(1):69-75. PubMed ID: 12893432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proline homozygosity in codon 72 of TP53 is a factor of susceptibility to nasopharyngeal carcinoma in Tunisia.
    Hadhri-Guiga B; Toumi N; Khabir A; Sellami-Boudawara T; Ghorbel A; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
    Cancer Genet Cytogenet; 2007 Oct; 178(2):89-93. PubMed ID: 17954263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development.
    Sousa H; Santos AM; Catarino R; Pinto D; Vasconcelos A; Lopes C; Breda E; Medeiros R
    Eur J Cancer Prev; 2006 Aug; 15(4):362-6. PubMed ID: 16835507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma.
    Tsai MH; Lin CD; Hsieh YY; Chang FC; Tsai FJ; Chen WC; Tsai CH
    Laryngoscope; 2002 Jan; 112(1):116-9. PubMed ID: 11802048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer.
    Han JY; Lee GK; Jang DH; Lee SY; Lee JS
    Cancer; 2008 Aug; 113(4):799-807. PubMed ID: 18618574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese.
    Sun Y; Hildesheim A; Li H; Li Y; Chen JY; Cheng YJ; Hayes RB; Rothman N; Bi WF; Cao Y
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):261-7. PubMed ID: 7606201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of p53 codon 72 polymorphism and survival of North Indian lung cancer patients treated with platinum-based chemotherapy.
    Kumari A; Bahl C; Singh N; Behera D; Sharma S
    Mol Biol Rep; 2016 Dec; 43(12):1383-1394. PubMed ID: 27614750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma.
    Ho KY; Kuo WR; Chai CY; Tsai SM; Sheu SH; Wu SC; Juan KH
    Laryngoscope; 2001 Jan; 111(1):131-6. PubMed ID: 11192881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 codon 72 polymorphism and the risk of lung cancer in a Korean population.
    Piao JM; Kim HN; Song HR; Kweon SS; Choi JS; Yun WJ; Kim YC; Oh IJ; Kim KS; Shin MH
    Lung Cancer; 2011 Sep; 73(3):264-7. PubMed ID: 21316118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of p53 codon 72 polymorphism on the survival outcome in advanced stage cervical cancer patients in India.
    Bansal A; Das P; Kannan S; Mahantshetty U; Mulherkar R
    Indian J Med Res; 2016 Sep; 144(3):359-365. PubMed ID: 28139534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia.
    Malisic E; Jankovic R; Slavkovic D; Milovic-Kovacevic M; Radulovic S
    J BUON; 2010; 15(1):101-6. PubMed ID: 20414935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of p53 mutations in primary nasopharyngeal carcinoma (NPC) in non-Asians of Los Angeles, California, a low-risk population for NPC.
    Van Tornout JM; Spruck CH; Shibata A; Schmutte C; Gonzalez-Zulueta M; Nichols PW; Chandrasoma PT; Yu MC; Jones PA
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):493-7. PubMed ID: 9232335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients.
    Liu LT; Chen QY; Tang LQ; Guo SS; Guo L; Mo HY; Chen MY; Zhao C; Guo X; Qian CN; Zeng MS; Bei JX; Tan J; Chen S; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
    Cancer Res Treat; 2018 Jan; 50(1):19-29. PubMed ID: 28392551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
    Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
    Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation.
    Tu HF; Chen HW; Kao SY; Lin SC; Liu CJ; Chang KW
    Radiother Oncol; 2008 May; 87(2):243-52. PubMed ID: 18423915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.